{"id":21592,"date":"2023-01-18T13:03:35","date_gmt":"2023-01-18T12:03:35","guid":{"rendered":"https:\/\/www.izb-online.de\/unternehmen\/atriva-therapeutics-gmbh\/"},"modified":"2023-01-18T14:40:25","modified_gmt":"2023-01-18T13:40:25","slug":"atriva-therapeutics-gmbh","status":"publish","type":"gco_companies","link":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/","title":{"rendered":"Atriva Therapeutics GmbH"},"content":{"rendered":"

[vc_row][vc_column][\/vc_column][\/vc_row][vc_row el_class=”container-inner”][vc_column][vc_row_inner][vc_column_inner el_class=”gco-tmpl-company__image-column” width=”1\/2″ offset=”vc_col-lg-4 vc_col-md-4″][vc_single_image image=”21586″ img_size=”full” el_class=”gco-tmpl-company__image”][vc_column_text el_class=”gco-tmpl-company__image-info-copyright”]Atriva Therapeutics[\/vc_column_text][vc_column_text el_class=”gco-tmpl-company__image-info-desc”]Atriva Therapeutics GmbH<\/p>\n

Christian M. Pangratz, CEO[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/2″ offset=”vc_col-lg-8 vc_col-md-8″][vc_column_text el_class=”gco-company-post-heading”]<\/p>\n

About Atriva Therapeutics<\/h3>\n

[\/vc_column_text][vc_column_text]Atriva Therapeutics GmbH, with additional sites in T\u00fcbingen and Frankfurt am Main, Germany, is pursuing a novel approach to combating known and unknown viral respiratory infectious diseases, such as COVID-19 and influenza, using host cell proteins rather than the virus for therapy. Atriva’s lead product, zapnometinib (ATR-002), is a first-in-class host-targeted agent that inhibits viral replication and favorably affects the body’s immune response to RNA viruses. In September 2022, Atriva had published promising topline results from the proof of concept (POC)\/phase 2a RESPIRE (zapnometinib) trial in patients with COVID-19.[\/vc_column_text][vc_column_text el_class=”gco-company-post-heading”]<\/p>\n

\n
\n
\n
\n

What ist your motivation?<\/h3>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_column_text]<\/p>\n

\n
\n
\n
\n

Even during the\u00a0ongoing pandemic, infectious diseases remain largely ignored with respect to the discovery of innovative therapeutics and significant financial investments. Relevant communities prefer to stick to established approaches such as directly acting antivirals in response to upcoming threats. We at ATRIVA see a unique opportunity with a host cell-based anti-viral approach ultimately providing medicines for a world free from pandemic threats. By using a host cell target as point of intervention, ATRIVA can simultaneously tackle multiple viruses using one target that these viruses require for replication and disease evolution. Through our dual-effect approach, we limit viral proliferation, and cope with the derailed immune system in parallel; at the same time, we avoid resistance formation. This new and exciting anti-viral solution drives us and our work at ATRIVA Therapeutics with the vision to help mankind live a life free from pandemic threats.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column width=”1\/2″ offset=”vc_col-lg-4 vc_col-md-4″][\/vc_column][vc_column width=”1\/2″ el_class=”gco-tmpl-company-quote” offset=”vc_col-lg-8 vc_col-md-8″][vc_column_text el_class=”gco-tmpl-company-quote__text”]”We are delighted to move into the IZB, the hot spot for life sciences in Munich. The interdisciplinary exchange with the network of world-class scientists located there will support us in our next steps to strengthen Atriva’s pioneering role as an innovator of host cell-based antiviral drugs.”[\/vc_column_text][vc_column_text el_class=”gco-tmpl-company-quote__source”]Christian M. Pangratz<\/p>\n

CEO Atriva Therapeutics[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"featured_media":21277,"template":"","meta":{"_links_to":"","_links_to_target":""},"company-categories":[157],"class_list":["post-21592","gco_companies","type-gco_companies","status-publish","has-post-thumbnail","hentry","company-categories-ehemalige"],"yoast_head":"\nAtriva Therapeutics GmbH - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atriva Therapeutics GmbH\" \/>\n<meta property=\"og:description\" content=\"Atriva TherapeuticsAtriva Therapeutics GmbH Christian M. Pangratz, CEO About Atriva Therapeutics Atriva Therapeutics GmbH, with additional sites in\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-18T13:40:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/11\/Atriva_Logo-e1669117168733.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"521\" \/>\n\t<meta property=\"og:image:height\" content=\"208\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/atriva-therapeutics-gmbh\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/atriva-therapeutics-gmbh\\\/\",\"name\":\"Atriva Therapeutics GmbH - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/atriva-therapeutics-gmbh\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/atriva-therapeutics-gmbh\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/Atriva_Logo-e1669117168733.jpg\",\"datePublished\":\"2023-01-18T12:03:35+00:00\",\"dateModified\":\"2023-01-18T13:40:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/atriva-therapeutics-gmbh\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/atriva-therapeutics-gmbh\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/atriva-therapeutics-gmbh\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/Atriva_Logo-e1669117168733.jpg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2022\\\/11\\\/Atriva_Logo-e1669117168733.jpg\",\"width\":521,\"height\":208,\"caption\":\"Atriva Therapeutics Logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/unternehmen\\\/atriva-therapeutics-gmbh\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ehemalige Startups\",\"item\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/company-categories\\\/ehemalige-en\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Atriva Therapeutics GmbH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"name\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"description\":\"Innovations- und Gr\u00fcnderzentrum Biotechnologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#organization\",\"name\":\"F\u00f6rdergesellschaft IZB mbH\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.izb-online.de\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/izb-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"F\u00f6rdergesellschaft IZB mbH\"},\"image\":{\"@id\":\"https:\\\/\\\/www.izb-online.de\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Atriva Therapeutics GmbH - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/","og_locale":"en_US","og_type":"article","og_title":"Atriva Therapeutics GmbH","og_description":"Atriva TherapeuticsAtriva Therapeutics GmbH Christian M. Pangratz, CEO About Atriva Therapeutics Atriva Therapeutics GmbH, with additional sites in","og_url":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/","og_site_name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","article_modified_time":"2023-01-18T13:40:25+00:00","og_image":[{"width":521,"height":208,"url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/11\/Atriva_Logo-e1669117168733.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/","url":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/","name":"Atriva Therapeutics GmbH - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/www.izb-online.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/#primaryimage"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/#primaryimage"},"thumbnailUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/11\/Atriva_Logo-e1669117168733.jpg","datePublished":"2023-01-18T12:03:35+00:00","dateModified":"2023-01-18T13:40:25+00:00","breadcrumb":{"@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/#primaryimage","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/11\/Atriva_Logo-e1669117168733.jpg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2022\/11\/Atriva_Logo-e1669117168733.jpg","width":521,"height":208,"caption":"Atriva Therapeutics Logo"},{"@type":"BreadcrumbList","@id":"https:\/\/www.izb-online.de\/en\/unternehmen\/atriva-therapeutics-gmbh\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.izb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"Ehemalige Startups","item":"https:\/\/www.izb-online.de\/en\/company-categories\/ehemalige-en\/"},{"@type":"ListItem","position":3,"name":"Atriva Therapeutics GmbH"}]},{"@type":"WebSite","@id":"https:\/\/www.izb-online.de\/en\/#website","url":"https:\/\/www.izb-online.de\/en\/","name":"Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"Innovations- und Gr\u00fcnderzentrum Biotechnologie","publisher":{"@id":"https:\/\/www.izb-online.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.izb-online.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.izb-online.de\/en\/#organization","name":"F\u00f6rdergesellschaft IZB mbH","url":"https:\/\/www.izb-online.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","contentUrl":"https:\/\/www.izb-online.de\/wp-content\/uploads\/2020\/06\/izb-logo.svg","width":1,"height":1,"caption":"F\u00f6rdergesellschaft IZB mbH"},"image":{"@id":"https:\/\/www.izb-online.de\/en\/#\/schema\/logo\/image\/"}}]}},"gco_companies_contact_fax":"","gco_companies_contact_fon":"+49 7071 8597673","gco_companies_contact_email":"info@atriva-therapeutics.com","gco_companies_contact_website_url":"https:\/\/www.atriva-therapeutics.com","gco_companies_contact_website_link_text":"","gco_companies_contact_street":"Am Klopferspitz 19","gco_companies_contact_zip":"82152","gco_companies_contact_city":"Planegg-Martinsried","gco_companies_contact_country":"Germany","gco_companies_info_business_area":"","_links":{"self":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_companies\/21592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/gco_companies"}],"about":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/types\/gco_companies"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media\/21277"}],"wp:attachment":[{"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/media?parent=21592"}],"wp:term":[{"taxonomy":"company-categories","embeddable":true,"href":"https:\/\/www.izb-online.de\/en\/wp-json\/wp\/v2\/company-categories?post=21592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}